{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:38:56Z","timestamp":1786653536993,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Recent research indicates that non-steroidal anti-inflammatory drugs may interfere in coagulation process and platelet aggregation. However, the potential of piroxicam in thrombotic and cardiopulmonary disorders remained unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To bridge this knowledge gap, the current study was conducted to assess the potential of piroxicam as antithrombotic and cardiopulmonary protective agent using multi-level approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>Piroxicam was docked against 16 key proteins involved in thrombotic and cardiopulmonary conditions. Its antiplatelet effect was evaluated by arachidonic acid (AA) and adenosine diphosphate (ADP)-induced aggregation while its effect on coagulation parameters were also evaluated. Cardiopulmonary protective effect in rats was investigated through isoproterenol induced myocardial infarction (MI) and self-embolus induced pulmonary embolism (PE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Strong binding interactions were identified, with docking energies of \u2265-9.0 kcal\/mol noted for cyclooxygenase (COX) 1, glycopotein-IIb\/IIIa, antithrombin-III, COX-2, and nuclear factor Kappa-B (NFkB). Piroxicam significantly inhibited AA and ADP-induced platelet aggregation (IC50: 0.68 and 24.9 \u03bcM) and also prolonged the prothrombin, activated partial thromboplastin, thrombin, and clot lysis time. Piroxicam markedly and in a dose-related manner lowered MI and PE associated serum markers in experimental rats. Piroxicam further safeguarded cardiac and pulmonary tissues from infarction and histopathological injury through the suppression of oxidative imbalance and inflammatory activity. This protective outcome was also due to reduced expression of tissue necrosis factor-\u03b1, NFkB, COX-2, NLRP3, and platelet-derived growth factor-\u03b2, verified using immunohistochemistry, enzyme-linked immunosorbent assay, and real-time polymerase chain reaction RT-PCR techniques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>These results indicate the prophylactic potential of piroxicam in cardiopulmonary thrombotic disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_944_25","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:02:23Z","timestamp":1777575743000},"page":"230-238","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing piroxicam for antithrombotic and cardiopulmonary protection: Pharmacological rationale and therapeutic potential"],"prefix":"10.4103","volume":"58","author":[{"given":"Waseem","family":"Khalid","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 04405, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif-Ullah","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 04405, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"R1-20260501","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: Epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"R2-20260501","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/ATVBAHA.124.320151","article-title":"Global health burden of venous thromboembolism","volume":"44","author":"Wendelboe","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R3-20260501","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R4-20260501","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCRESAHA.124.323579","article-title":"What it takes to be a platelet: Evolving concepts in platelet production","volume":"135","author":"Carminita","year":"2024","journal-title":"Circ Res"},{"key":"R5-20260501","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s44313-024-00040-8","article-title":"Back to basics: The coagulation pathway","volume":"59","author":"Park","year":"2024","journal-title":"Blood Res"},{"key":"R6-20260501","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"R7-20260501","first-page":"27","article-title":"An In-silico comparative study of binding affinities and binding orientations of isoniazid synthetic analogues to InhA by AutoDock and AutoDock vina","volume":"2","author":"Naeem","year":"2024","journal-title":"RADS J Pharm Allied Health Sci"},{"key":"R8-20260501","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1002\/cpz1.1095","article-title":"Whole blood aggregometry in mice","volume":"4","author":"Branfield","year":"2024","journal-title":"Curr Protoc"},{"key":"R9-20260501","doi-asserted-by":"crossref","first-page":"e15311225439","DOI":"10.33448\/rsd-v11i2.25439","article-title":"Evaluation of partial thromboplastin time, thrombin time and prothrombin time over treated plasma using a fibrinolytic protease","volume":"11","author":"Miranda","year":"2022","journal-title":"Res Soc Dev"},{"key":"R10-20260501","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejphar.2008.02.057","article-title":"Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat","volume":"586","author":"Zhou","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R11-20260501","first-page":"146","article-title":"Inflammatory response induced in pulmonary embolic lung: Evaluation using a reproducible murine pulmonary embolism model","volume":"11","author":"Okabe","year":"2022","journal-title":"Glob J Biol Agric Health Sci"},{"key":"R12-20260501","first-page":"23","article-title":"Curcumin alleviates myocardial inflammation, apoptosis, and oxidative stress induced by acute pulmonary embolism by regulating microRNA-145-5P\/insulin receptor substrate 1 axis","volume":"75","author":"Jiang","year":"2024","journal-title":"J Physiol Pharmacol"},{"key":"R13-20260501","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1039\/C8FO01281D","article-title":"Chlorogenic acid methyl ester exerts strong anti-inflammatory effects via inhibiting the COX-2\/NLRP3\/NF-kB pathway","volume":"9","author":"Zhang","year":"2018","journal-title":"Food Funct"},{"key":"R14-20260501","doi-asserted-by":"crossref","first-page":"103681","DOI":"10.1016\/j.jpet.2025.103681","article-title":"Antithrombotic potential of lornoxicam:possible mechanistic pathways","volume":"392","author":"Khalid","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-20260501","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/molecules25061375","article-title":"A review on applications of computational methods in drug screening and design","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"key":"R17-20260501","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/bioinformatics\/btl079","article-title":"Predicting protein interaction sites: Binding hot-spots in protein-protein and protein-ligand interfaces","volume":"22","author":"Burgoyne","year":"2006","journal-title":"Bioinformatics"},{"key":"R18-20260501","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-6147(03)00077-4","article-title":"Prevention of thrombosis and vascular inflammation: Benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors","volume":"24","author":"de","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"R19-20260501","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.biopha.2017.06.086","article-title":"Shikonin ameliorates isoproterenol (ISO)-induced myocardial damage through suppressing fibrosis, inflammation, apoptosis and ER stress","volume":"93","author":"Yang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"R20-20260501","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/ph17111488","article-title":"Exploring COX-independent pathways: A novel approach for meloxicam and other NSAIDs in cancer and cardiovascular disease treatment","volume":"17","author":"Cheng","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"R21-20260501","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R22-20260501","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1389203723666220817085941","article-title":"The role of NF-kB in myocardial ischemia\/reperfusion injury","volume":"23","author":"Dong","year":"2022","journal-title":"Curr Protein Pept Sci"},{"key":"R23-20260501","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/cells11060922","article-title":"Biomarkers associated with cardiovascular disease in COVID-19","volume":"11","author":"Kaufmann","year":"2022","journal-title":"Cells"},{"key":"R24-20260501","doi-asserted-by":"crossref","first-page":"103681","DOI":"10.1016\/j.jpet.2025.103681","article-title":"Antithrombotic potential of lornoxicam and possible mechanistic pathways","volume":"392","author":"Khalid","year":"2025","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_944_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:57Z","timestamp":1786649937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_944_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_944_25","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-09-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}